NewsPhysiciansResearchers

ADVANCED MEDICAL TECHNOLOGY ASSOCIATION PREDICT 25 MILLION TESTS AVAILABLE BY END OF APRIL

 

 

The medical device industry projects there will be 25 million diagnostic tests made for the coronavirus strain COVID-19 for U.S. use by the end of April, according to projections April 23 by Advanced Medical Technology Association (AdvaMed) .

 

“Our industry is focused on scaling up the number of tests available . . . from reagents to supplies to component parts,” Scott Whitaker, chief executive officer of AdvaMed told reporters in a conference call Wednesday morning. “The scale at which people are demanding tests requires speed over anything now.”

AdvaMed didn’t disclose which companies were producing tests but said the industry is focused on diagnostic tests that can be used to detect the Coronavirus strain COVID-19. AdvaMed’s numbers don’t include serology or antibody tests designed to detect whether someone has had the virus and are also being developed. VTN

 

Previous post

LARGE NY COVID-19 STUDY PRESENTS CHARACTERISTICS, COMORBIDITIES, OUTCOMES OF 5,700 PATIENTS

Next post

AVLS GOES HYBRID FOR ITS 34TH ANNUAL CONGRESS OFFERING IN-PERSON AND VIRTUAL ATTENDANCE

Larry Storer

Larry Storer

Larry Storer has been editor of Vein Therapy News for 10 years. He has edited computer, shelter and medical publications at Publications & Communications LP for 30 years. He was also a corporate vice president and editorial director before retiring. Larry graduated from Baylor University with a BA in journalism and an MA in communications; and from Lamar University with a MED in school administration. He taught beginning and advanced reporting, beginning and advanced editing and editorial writing at Baylor University. Larry was a reporter, and city and news editor of the Beaumont Journal, and opinion editor at the Beaumont Enterprise and Beaumont Enterprise-Journal. He was also the founding managing editor of the Yuba City (California) Daily Independent-Herald.